Annual Report — Form 10-K — SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.56M
2: EX-4.2 Instrument Defining the Rights of Security Holders HTML 142K
3: EX-21.1 Subsidiaries List HTML 35K
4: EX-23.1 Consent of Expert or Counsel HTML 31K
9: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 53K
Awarded Compensation
5: EX-31.1 Certification -- §302 - SOA'02 HTML 38K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 38K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 34K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 34K
11: R1 Cover Page HTML 107K
12: R2 Condensed Consolidated Balance Sheets HTML 166K
13: R3 Condensed Consolidated Balance Sheets HTML 40K
(Parenthetical)
14: R4 Consolidated Statements of Operations HTML 133K
15: R5 Consolidated Statements of Comprehensive Loss HTML 67K
16: R6 Condensed Consolidated Statements of Redeemable HTML 91K
Noncontrolling Interests and Stockholders' Equity
(Deficit)
17: R7 Condensed Consolidated Statements of Cash Flows HTML 160K
18: R8 Nature of Business HTML 40K
19: R9 Basis of Presentation, Consolidation and Summary HTML 135K
of Significant Accounting Policies
20: R10 Dispositions HTML 47K
21: R11 Variable Interest Entities and a Voting Interest HTML 391K
Entity
22: R12 Equity Method Investments and Other Investments HTML 208K
23: R13 Notes Receivable HTML 67K
24: R14 Fair Value Measurement HTML 277K
25: R15 Prepaid Expenses and Other Current Assets HTML 47K
26: R16 Accrued Liabilities HTML 49K
27: R17 Leases HTML 85K
28: R18 Debt HTML 99K
29: R19 Common Stock HTML 49K
30: R20 Stock-Based Compensation HTML 195K
31: R21 Income Taxes HTML 210K
32: R22 Net Loss Per Share HTML 75K
33: R23 Commitments and Contingencies HTML 41K
34: R24 License Agreements HTML 68K
35: R25 Related Party Transactions HTML 46K
36: R26 Defined Contribution Plan HTML 35K
37: R27 Corporate Restructuring HTML 39K
38: R28 Subsequent Events HTML 41K
39: R29 Basis of Presentation, Consolidation and Summary HTML 189K
of Significant Accounting Policies (Policies)
40: R30 Variable Interest Entities and a Voting Interest HTML 379K
Entity (Tables)
41: R31 Equity Method Investments and Other Investments HTML 137K
(Tables)
42: R32 Fair Value Measurement (Tables) HTML 232K
43: R33 Prepaid Expenses and Other Current Assets (Tables) HTML 47K
44: R34 Accrued Liabilities (Tables) HTML 49K
45: R35 ROU assets and lease liabilities (Tables) HTML 43K
46: R36 Lease Costs (Tables) HTML 45K
47: R37 Future minimum commitments under all HTML 46K
non-cancelable operating leases (Tables)
48: R38 Supplemental cash flow information related to the HTML 44K
Company's operating lease (Tables)
49: R39 Debt (Tables) HTML 53K
50: R40 Stock-Based Compensation (Tables) HTML 177K
51: R41 Income Taxes (Tables) HTML 200K
52: R42 Net Loss Per Share (Tables) HTML 72K
53: R43 Nature of Business - Additional Information HTML 54K
(Detail)
54: R44 Basis of Presentation, Consolidation and Summary HTML 60K
of Significant Accounting Policies - Additional
Information (Detail)
55: R45 Dispositions - Additional Information (Detail) HTML 43K
56: R46 Variable Interest Entities and a Voting Interest HTML 75K
Entity - Additional information (Detail)
57: R47 Variable Interest Entities and a Voting Interest HTML 67K
Entity - Summary of Primary Beneficiary for VIEs
Consolidated Under the VIE Model (Detail)
58: R48 Variable Interest Entities and a Voting Interest HTML 136K
Entity - Summary of the Assets and Liabilities for
all Consolidated VIEs (Detail)
59: R49 Variable Interest Entities and a Voting Interest HTML 59K
Entity - Schedule of Non Controlling Interest
Recognized to Its Consolidated VIEs Roll Forward
(Detail)
60: R50 Equity Method Investments and Other Investments - HTML 53K
Summary of Equity Method Investments (Detail)
61: R51 Equity Method Investments and Other Investments - HTML 40K
Summary of Equity Method Investments and Other
Investments (Detail)
62: R52 Equity Method Investments and Other Investments - HTML 88K
Summary of financial data for investments (Detail)
63: R53 Equity Method Investments and Other Investments - HTML 68K
Summary of Statements of operations (Detail)
64: R54 Equity Method Investments and Other Investments - HTML 302K
Additional information (Detail)
65: R55 Equity Method Investments and Other Investments - HTML 72K
Securities Purchase Agreement - Additional
information (Detail)
66: R56 Notes Receivable - Additional Information (Detail) HTML 195K
67: R57 Fair Value Measurement - Summary of Fair Value HTML 93K
Measurement on Recurring Basis (Detail)
68: R58 Fair Value Measurement - Summary of Fair Value HTML 63K
Measurement Inputs and Valuation Techniques
(Detail)
69: R59 Fair Value Measurement - Summary of Fair Value HTML 73K
Measurement on Recurring Basis, Unobservable Input
Reconciliation (Detail)
70: R60 Fair Value Measurement - Additional Information HTML 105K
(Detail)
71: R61 Prepaid Expenses and Other Current Assets - HTML 43K
Summary of Prepaid Expenses and Other Current
Assets (Detail)
72: R62 Accrued Liabilities - Summary of Accrued HTML 44K
Liabilities (Detail)
73: R63 Leases (Additional Information) (Details) HTML 45K
74: R64 Leases - ROU assets and lease liabilities HTML 42K
(Details)
75: R65 Leases - lease costs (Details) HTML 40K
76: R66 Leases - Future minimum commitments under all HTML 48K
non-cancelable operating leases (Details)
77: R67 Leases - Supplemental cash flow information HTML 35K
related to the Company's operating leases
(Details)
78: R68 Debt - Summary of Convertible Promissory Notes HTML 42K
(Detail)
79: R69 Debt - Additional Information (Detail) HTML 160K
80: R70 Debt - Schedule of Outstanding Debt Obligations HTML 53K
(Detail)
81: R71 Debt- Summary of Grant Date Fair Value (Details) HTML 42K
82: R72 Common Stock - Additional Information (Detail) HTML 80K
83: R73 Stock-Based Compensation - Summary of share based HTML 81K
Payment Arrangement Option Activity (Detail)
84: R74 Stock-Based Compensation - Summary of vested and HTML 60K
non vested option outstanding (Parenthetical)
(Details)
85: R75 Stock-Based Compensation - Schedule of Share-based HTML 55K
Payment Award, Stock Options, Valuation
Assumptions (Detail)
86: R76 Stock-Based Compensation - Summary of restricted HTML 54K
stock unit activity (Details)
87: R77 Stock-Based Compensation - Summary of Employee HTML 76K
Stock Ownership Plan (ESOP) Disclosures (Detail)
88: R78 Stock-Based Compensation - Summary of Share-based HTML 42K
Compensation Arrangements by Share-based Payment
Award (Detail)
89: R79 Stock-Based Compensation - Additional Information HTML 107K
(Detail)
90: R80 Stock-Based Compensation - Summary of restricted HTML 54K
stock awards (Details)
91: R81 Income Taxes - Additional Information (Detail) HTML 62K
92: R82 Income Taxes - Schedule of Income before Income HTML 42K
Tax, German and Overseas (Details)
93: R83 Income Taxes - Schedule of Components of Income HTML 54K
Tax Provision (Benefit) (Details)
94: R84 Income Taxes - Schedule of Effective Income Tax HTML 73K
Rate Reconciliation (Details)
95: R85 Income Taxes - Summary of Components of Deferred HTML 68K
Tax Assets and Deferred Tax Liabilities (Details)
96: R86 Income Taxes - Schedule of Gross Tax Loss HTML 37K
Carryforward for Tax Return Purpose (Details)
97: R87 Income Taxes - Schedule of Unrecognized Tax HTML 40K
Benefits (Details)
98: R88 Net Loss Per Share - Summary of Basic and Diluted HTML 77K
Net Loss Per Share (Detail)
99: R89 Net Loss Per Share - Schedule of Potentially HTML 48K
dilutive securities to the Company's common shares
(Detail)
100: R90 Net Loss Per Share - Additional Information HTML 43K
(Detail)
101: R91 License Agreements - Additional Information HTML 94K
(Detail)
102: R92 Related Party Transactions - Additional HTML 65K
Information (Detail)
103: R93 Defined Contribution Plan - Additional HTML 33K
Information) (Details)
104: R94 Corporate Restructuring - Additional Information) HTML 49K
(Details)
105: R95 Subsequent Events - Additional Information HTML 67K
(Detail)
107: XML IDEA XML File -- Filing Summary XML 210K
110: XML XBRL Instance -- atai-20231231_htm XML 4.76M
106: EXCEL IDEA Workbook of Financial Report Info XLSX 214K
10: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 7.77M
Linkbases Document -- atai-20231231
108: JSON XBRL Instance as JSON Data -- MetaLinks 811± 1.23M
109: ZIP XBRL Zipped Folder -- 0000950170-24-038138-xbrl Zip 2.58M
‘EXCEL’ — IDEA Workbook of Financial Report Info
This is an IDEA Workbook.
16 Previous Filings that this Filing References
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent
2/06/24 ATAI Life Sciences N.V. 8-K:5,7,9 2/01/24 12:238K Broadridge Fin’l So… Inc
1/23/24 ATAI Life Sciences N.V. 8-K:1,2,9 1/18/24 11:538K Broadridge Fin’l So… Inc
1/09/24 ATAI Life Sciences N.V. 8-K:8,9 1/07/24 11:220K Broadridge Fin’l So… Inc
1/04/24 ATAI Life Sciences N.V. 8-K:1,2,7,9 1/03/24 13:2.6M Broadridge Fin’l So… Inc
11/14/23 ATAI Life Sciences N.V. 10-Q 9/30/23 103:22M Donnelley … Solutions/FA
8/31/23 ATAI Life Sciences N.V. 8-K:5,9 8/25/23 12:450K Donnelley … Solutions/FA
5/31/23 ATAI Life Sciences N.V. 8-K:1,2,9 5/26/23 11:719K Broadridge Fin’l So… Inc
3/24/23 ATAI Life Sciences N.V. 10-K 12/31/22 107:38M Donnelley … Solutions/FA
11/10/22 ATAI Life Sciences N.V. 8-K:1,9 11/10/22 12:448K Donnelley … Solutions/FA
11/10/22 ATAI Life Sciences N.V. 10-Q 9/30/22 90:27M Donnelley … Solutions/FA
8/15/22 ATAI Life Sciences N.V. 8-K:1,2,7,9 8/09/22 12:707K Donnelley … Solutions/FA
8/16/21 ATAI Life Sciences N.V. 10-Q 6/30/21 6:2.1M Donnelley … Solutions/FA
6/11/21 ATAI Life Sciences N.V. S-1/A 25:7.6M Donnelley … Solutions/FA
6/04/21 ATAI Life Sciences N.V. S-1/A 4:247K Donnelley … Solutions/FA
5/27/21 ATAI Life Sciences N.V. S-1/A 5:6.4M Donnelley … Solutions/FA
4/20/21 ATAI Life Sciences N.V. S-1 19:6.2M Donnelley … Solutions/FA
|
↑Top
Filing Submission 0000950170-24-038138 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Sun., May 12, 2:58:13.1am ET 
